Show simple item record

dc.rights.licenseCC-BY-NC-ND
dc.contributor.advisorDerksen, P.W.B.
dc.contributor.authorPustjens, M.F.
dc.date.accessioned2012-07-05T17:01:44Z
dc.date.available2012-07-05
dc.date.available2012-07-05T17:01:44Z
dc.date.issued2012
dc.identifier.urihttps://studenttheses.uu.nl/handle/20.500.12932/10707
dc.description.abstractThe most common malignancy in women of the Western World is breast cancer, which develops from mammary gland epithelium. 30-40% of the patients develop metastatic disease, the primary cause of death. Abnormal E-cadherin expression and disturbed adherens junctions (AJs) are often observed. A disturbance in interaction between proteins in the E-cadherin-catenin complex is one of the main events in both early and late steps of cancer development. AJs have a role in the initiation and stabilization of cell-cell adhesion, regulation of the actin cytoskeleton, intracellular signalling and transcriptional regulation. α-catenin, a protein from the AJ complex, may have a role as a molecular switch that connects the E-cadherin-β-catenin complex to the actin cytoskeleton. Besides its function as a linker, it coordinates actin dynamics and has an influence on cell proliferation, migration, invasion and adhesion. Knockout studies showed that loss of α-catenin leads to compromised AJs and impairment of cell-cell adhesion, increased proliferation and migration. α-catenin is crucial for tissue integrity. Many cancers, such as breast, kidney and skin cancer show mutations in the α-catenin gene, CTNNA1.
dc.description.sponsorshipUtrecht University
dc.format.extent710122 bytes
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.titleα-catenin in the adherens junction complex and the possible implications in cancer
dc.type.contentMaster Thesis
dc.rights.accessrightsOpen Access
dc.subject.keywordsalpha-catenin, adherens junctions, breast cancer
dc.subject.courseuuBiology of Disease


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record